A prognostic index for ductal carcinoma in situ of the breast.
about
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breastThe diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesionsThe diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification8th international conference: primary therapy of early breast cancer, St Gallen, Switzerland, March 12-15 2003Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breastS100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breastCorrelation between imaging and pathology in ductal carcinoma in situ of the breastRadiotherapy of Ductal Carcinoma In SituCurrent view on ductal carcinoma in situ and importance of the margin thresholds: A reviewMain controversies in breast cancerBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry.Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.Ultrasound findings and histological features of ductal carcinoma in situ detected by ultrasound examination alone.DCIS grading schemes and clinical implications.Ductal carcinoma in situ of the breast.Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.Ductal carcinoma in situ of the breast--a review of diagnosis, treatment and outcome in a hospital-based Norwegian series.A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trialIs radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the BreastThe Diagnosis and Treatment of Ductal Carcinoma In Situ of the Breast.Integration of breast MRI in clinical trials.Histologic classification of ductal carcinoma in situ.Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective.High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients.Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgery.Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.Patterns and correlates of local therapy for women with ductal carcinoma-in-situ
P2860
Q24685857-FFB98485-0AAD-41EE-BCB9-A0DAAFB75D8DQ24802837-1A9AF8CD-9F60-4D8F-8833-A3AD91DF54E2Q24803360-6E51ACEB-55F3-4B47-89F4-59835439B8FFQ24803899-5BA8CAB3-B609-4B21-AC1B-F0071E6F84E2Q24804937-9EB8BCFF-1553-4AF5-86DA-7D5AF63A930CQ24805971-767A5EEA-1E5F-497F-9DA1-06676A6A1DE2Q24806460-2D0CFCD4-1013-4C6E-AFE7-A495123E78AEQ26776277-9E4EDBE3-C91F-4668-9553-BEE51C041E5CQ26853548-EA964FE0-9913-443D-B2F9-27D8A7CAD75CQ27026673-AD6C5BA8-F8C4-4BF3-B004-8A29DAE8A471Q30245184-B4420C7F-A8DA-41D7-8A28-BD142809B509Q30409213-5961FA93-A6C2-4CE2-99F7-4A8465FE36B4Q30512858-DAB3F98E-440E-4FEE-8E68-44E997EFC851Q31169382-C6E53A91-ECC6-4AEF-B1C2-400DCE02EB2CQ33293401-94068369-9430-49CB-A733-AD47861B5F27Q33334654-C5DC4723-2F03-4274-A568-8D2B89F701D2Q33697985-8A00E0C5-C2D5-499D-AB1B-D05AEA304933Q33765776-9CEDE33E-EC4C-4383-8C3F-245DBF8CC026Q33779064-D65DDBD9-B194-4DF9-AF09-A1386C84531CQ33785753-B3E9F7FC-33F2-4FF9-8520-9FA26478F229Q33791890-2FB1A1B6-DBA2-4742-98E0-7E7013C59383Q33825299-5E5C7720-2029-45F0-B48B-85CDE3302650Q33945901-E41214D0-7B20-4599-A174-D99ACE3B7F4AQ34000255-AD0214C8-78FD-4FD5-9A85-4F96F89FF3D9Q34043363-0CD295D8-0BCA-4C36-886F-F9D81698363DQ34154192-EAC6A1BC-6B1B-4674-82CA-285F7B95250FQ34159460-C1961A2C-32D8-4895-B668-CAF9D0BB6C14Q34207931-703A6EED-78C1-40E4-8B1D-39A157830154Q34248654-2F14658E-12ED-4D23-9024-0347887B9FC9Q34267795-27DA987A-74B9-42DC-836E-FA1F7B63CD96Q34954853-D816D79E-4247-4696-B7AA-6B51EB7480F8Q35012751-0D6AC280-85D7-4202-89DD-3AF77FFAB261Q35069457-4B12C9C0-DCB0-43F1-9F57-2BCE1CE27FE6Q35109188-26BBD245-5BF7-4DB0-8C2A-4A1C50C8142DQ35170144-B856BEBA-872A-4666-AF62-5ED6B750751CQ35356251-8A3DFD41-69BD-4512-B39B-50FE7C98E400Q35584710-581A7937-44D5-430E-8758-8BF1E6E8B575Q35586306-11BBA0A1-39E5-4657-B983-BA0DBB6B6053Q35586530-91D45BA2-D3A0-4999-864E-2D88178390AEQ35674899-48139F4A-17D3-4186-BBD7-DCF5AB142C99
P2860
A prognostic index for ductal carcinoma in situ of the breast.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
A prognostic index for ductal carcinoma in situ of the breast.
@en
A prognostic index for ductal carcinoma in situ of the breast.
@nl
type
label
A prognostic index for ductal carcinoma in situ of the breast.
@en
A prognostic index for ductal carcinoma in situ of the breast.
@nl
prefLabel
A prognostic index for ductal carcinoma in situ of the breast.
@en
A prognostic index for ductal carcinoma in situ of the breast.
@nl
P2093
P2860
P1433
P1476
A prognostic index for ductal carcinoma in situ of the breast.
@en
P2093
Colburn WJ
Lewinsky BS
Silverstein MJ
Waisman JR
P2860
P304
P356
10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V
P407
P577
1996-06-01T00:00:00Z